Earnings Call · Q2 FY2022·2022-08-15

Q2 22EPS +47.46%·Rev n/aQ1 22EPS +78.06%·Rev n/aQ4 21EPS -36.36%·Rev n/aQ3 21EPS +1.42%·Rev n/a⚠ consensus missing

SCYNEXIS INC SCYX

Debbie Etchison — Investor Relations or Corporate Communications

Dr. Marco Taglietti — Chief Executive Officer (CEO)

Christine Coyne — Commercial or Sales Executive

Dr. David Angulo — Chief Medical Officer (CMO)

Larry Hoffman — Finance Executive

+2.1%1d on move date+1.7% vs SPY3d+2.1%5d−4.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SCYX calls or request research access.

More SCYX calls Browse calls Request research access